First dedicated transcatheter leaflet splitting device: the ShortCut device

DOI: 10.4244/EIJ-D-22-00344

Didier Tchétché
Didier Tchétché1, MD; Susheel K. Kodali2, MD; Danny Dvir3, MD
1. Clinique Pasteur, Toulouse, France; 2. Columbia University Irving Medical Center, New York, NY, USA; 3. Shaare Zedek Medical Center, Jerusalem, Israel


Figure 1.  The Pi-Cardia ShortCut device. The ShortCut procedure:  A.  PA positioning; B. SE activation. The yellow circle shows splitting of the bioprosthetic leaflet facing the left main coronary artery; C. splitting; and D. good coronary flow post-split and TAVR. The arrow points to patency of the left main coronary artery at the end of the procedure. PA: positioning arm; SE: splitting element; TAVR: transcatheter aortic valve replacement

Coronary obstruction is a life-threatening complication that occurs in 2.3% of patients undergoing transcatheter aortic valve replacement (TAVR) for degenerated bioprostheses1. During a valve-in-valve (...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Chordal replacement and annuloplasty in one transfemoral device for degenerative mitral regurgitation

Latest news